Slide 1
CEO of VC backed healthcare technology company

Experience in organizations large and small in pharma, medical devices, payer, national retail pharmacy and of course the health system/ provider side…. informed and provided unmatched guidance in key areas of focus such as corporate strategy, competitive positioning, clinical trials, beta sites, sales and marketing etc.

Slide 2
Chair of chronic care start-up company

Source of great general business and management principals in areas such as hiring and recruiting CEO direct reports, managing key human resources and overall good business practices; in short has served as a key advisor to the CEO in manner uncommon to the typical director’s role.

Slide 3
President of diabetes technology company

The company’s success has been underpinned by its ‘evidence strategy,' the foundation of which was heavily influenced by Caluent designs of our clinical research program, and specifically various studies and sub-studies. Caluent played a central role in developing the template by which clinical and financial outcomes studies are conducted with providers, and also the various mechanisms which the results are shared with the healthcare community—whether in a pure clinical context or business /ROI focused context. From data collection, data analysis to statistical and economic modeling and several other key components. The results have had tremendous influence in helping the company gain the legitimacy necessary to developing a new market and achieving significant competitive advantage and sustained growth.

Slide 4
CEO, Device company Silicon Valley

Close to an acquisition process it became clear that we needed to specifically delineate the economical advantages to payers, hospitals and doctors. Caluent was able to quickly pull together accurate coding data, focus the economic argument and guide our commercial and reimbursement strategy. This was completed within days rather than weeks or months that we had been informed by others that it would take. The ability to operate on start-up time is a rare commodity.